Please assess the completion status of the following clinical trial:

Trial Title: Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis of gastric adenocarcinoma.~* Clinical stage cT2 or higher.~* No evidence of metastatic disease on preoperative imaging.~* Patient fit for surgery (ECOG 0 or 1).~Exclusion Criteria:~* Indocyanine allergy.~* Gastric cancer subtype other than gastric adenocarcinoma.~* Unconfirmed diagnosis of gastric adenocarcinoma (unable to confirm diagnosis).~* Clinical stage cT1b or lower.~* Evidence of metastatic disease on preoperative imaging.~* Patient unfit for surgery (ECOG 2 or more).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Gastric cancer with ICG (Type: EXPERIMENTAL): Patient to receive IV ICG during diagnostic laparoscopy.

Based on this trial design, predict the completion outcome and termination type (if applicable).